The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results.
Cardiovascular diseases are the leading causes of death worldwide. The cardioprotective effects of natural polyphenols such as resveratrol (3,5,4-trihydroxystilbene) have been extensively investigated throughout recent decades. Many studies of RES have focused on its favorable effects on pathological conditions related to cardiovascular diseases and their risk factors. The aim of this review was to summarize the wide beneficial effects of resveratrol on the cardiovascular system, including signal transduction pathways of cell longevity, energy metabolism of cardiomyocytes or cardiac remodeling, and its anti-inflammatory and antioxidant properties. In addition, this paper discusses the significant preclinical and human clinical trials of recent years with resveratrol on cardiovascular system. Finally, we present a short overview of antiviral and anti-inflammatory properties and possible future perspectives on RES against COVID-19 in cardiovascular diseases.
['Gal|Roland|R|0000-0003-4029-7913', 'Deres|Laszlo|L|', 'Toth|Kalman|K|0000-0002-0114-5231', 'Halmosi|Robert|R|0000-0002-6965-7743', 'Habon|Tamas|T|0000-0002-4816-857X']
D000818:Animals D000893:Anti-Inflammatory Agents D000975:Antioxidants D000086382:COVID-19 D002318:Cardiovascular Diseases D002319:Cardiovascular System D006801:Humans D000077185:Resveratrol
resveratrol cardiovascular diseases heart failure inflammation oxidative stress